Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients

Diabetes Care

Volumn 34, Issue 3, 2011, Pages 691-696

  Kamijo Ikemori, Atsuko ^a   Sugaya, Takeshi ^a   Yasuda, Takashi ^a   Kawata, Takehiro ^a   Ota, Akio ^a   Tatsunami, Shinobu ^a   Kaise, Ruriko ^b   Ishimitsu, Toshihiko ^c   Tanaka, Yasushi ^a   Kimura, Kenjiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Senpo Tokyo Takanawa Hospital   (Japan)

^c Dokkyo Medical University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; LIVER TYPE FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LONGITUDINAL STUDY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROTEIN URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 79956091555     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1392     Document Type: Article

References (9)

1. Sweetser DA, Heuckeroth RO, Gordon JI. The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of a function. Annu Rev Nutr 1987;7:337-359
2. Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acidbinding proteins. Biochim Biophys Acta 1991;1081:1-24
3. Veerkamp JH, van Kuppevelt TH, Maatman RG, Prinsen CF. Structural and functional aspects of cytosolic fatty acid-binding proteins. Prostaglandins Leukot Essent Fatty Acids 1993;49:887-906 (Pubitemid 24027467)
4. Kamijo A, Kimura K, Sugaya T, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004;143:23-30 (Pubitemid 38156413)
5. Matsuo S, Imai E, Horio M, et al.; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992
6. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006;17:17-25
7. Singh DK, Winocour P, Farrington K. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol 2008;4:216-226 (Pubitemid 351451302)
8. Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid - binding protein in acute ischemic injury. J Am Soc Nephrol 2007;18:2894-2902 (Pubitemid 350058396)
9. Nielsen SE, Sugaya T, Hovind P, Baba T, Parving HH, Rossing P. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 2010;33:1320-1324